prothrombin g20210a mutation is not a risk factor for pediatric acute lymphoblastic leukemia in western iran

نویسندگان

zohreh rahimi medical biology research center, kermanshah university of medical sciences, kermanshah, iran

ziba rahimi medical biology research center, kermanshah university of medical sciences, kermanshah, iran

reza akramipour department of pediatrics, kermanshah university of medical sciences, kermanshah, iran

چکیده

background : we conducted the present study to investigate the frequency of prothrombin g20210a mutation among acute lymphoblastic leukemia patients and healthy individuals from western iran and to detect the possible association between this mutation and the risk of acute lymphoblastic leukemia in our population. methods : the studied groups consisted of 92 children with acute lymphoblastic leukemia and 249 age- and sex-matched healthy children from western iran. the prothrombin g20210a mutation was identified by pcr-rflp using the restriction enzyme of hind iii. results : the prevalence of prothrombin 20210 ga genotype was 6.5% in patients and 3.2% in controls (p=0.17). the frequency of the a allele in patients was 3.3% and in controls it was1.6%. conclusion : the present study indicates the absence of any significant differences in the frequency of the prothrombin g20210a mutation between acute lymphoblastic leukemia patients and healthy individuals. the results suggest that this mutation may not be a risk factor for acute lymphoblastic leukemia in our population.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

The prothrombin G20210A mutation is a risk factor for sudden hearing loss in young patients.

6. Warner D, Mansfield MW, Grant PJ. Coagulation factor XIII and cardiovascular disease in UK Asian patients undergoing coronary angiography. Thromb Haemost 2001; 85: 408-11. 7. Kohler HP, Grant PJ. Clustering of haemostatic risk factors with FXIIIVal34Leu in patients with myocardial infarction. Thromb Haemost 1998; 80: 862. 8. Ariëns RAS, Kohler HP, Mansfield MW, Grant PJ. Subunit antigen and ...

متن کامل

Factor V Leiden, MTHFR C677T and Prothrombin Gene Mutation G20210A in Iranian Patients with Venous Thrombosis

Background: Factor V Leiden, Prothrombin gene (G20210A) and MTHFR (C677T) polymorphism are the main biomarkers for evaluation of tendency for venous thromboembolism. We aimed to investigate the frequency of mutations in factor V Leiden, Prothrombin G20210A and MTHFR C677T and identify the genetic status for these mutations in patients with venous thrombosis. Methods: This study was carried out...

متن کامل

UBE2Q1, as Down Regulated Gene in Pediatric Acute Lymphoblastic Leukemia

Ubiquitin - proteasome system (UPS), the major protein degradation pathway in the cells, typically degrades short - lived and damaged proteins and regulates growth and stress responses. This pathway is altered in various cancers, including Acute Lymphoblastic Leukemia (ALL). ALL begins with a change in bone marrow cells and is the most common type of leukemia in children under 15 years. UBE2Q1...

متن کامل

Pediatric Acute Lymphoblastic Leukemia

Results ETV6/RUNX1 had a strong effect on overall survival after relapse (3-year survival= 64.7% for positive cases versus 46.5% for negative cases) (P=0.007). The 5-year cumulative incidence of relapse was 19.4% and testes were more frequently involved in ETV6/RUNX1-positive relapses (P=0.04). In 81.4% of cases the relapses were late, early combined or isolated extramedullary relapses. The 5-y...

متن کامل

Pediatric Acute Lymphoblastic Leukemia

This review will focus on pediatric acute lymphoblastic leukemia (pALL), highlighting risk factors, classification, presentation, risk group assignment and treatment stratification, treatment, outcome, and long-term consequences of therapy. Other forms of pediatric leukemia, such as acute and chronic myeloid leukemia are not reviewed. The reader is referred to several recent publications review...

متن کامل

Pediatric acute lymphoblastic leukemia.

The outcome for children with acute lymphoblastic leukemia (ALL) has improved dramatically with current therapy resulting in an event free survival exceeding 75% for most patients. However significant challenges remain including developing better methods to predict which patients can be cured with less toxic treatment and which ones will benefit from augmented therapy. In addition, 25% of patie...

متن کامل

منابع من

با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید


عنوان ژورنال:
middle east journal of cancer

جلد ۴، شماره ۴، صفحات ۱۳۹-۰

کلمات کلیدی

میزبانی شده توسط پلتفرم ابری doprax.com

copyright © 2015-2023